Another study performed by Ong et al. in 2015 [44] showed that patients with T2DM with established microvascular complications have higher baseline concentrations of FGF21, which served as a prognostic indicator for the future emergence of novel microvascular complications during a 5-year follow up [48]. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.